Peroxisome Proliferator-Activated Receptor Alpha Mediates the Beneficial Effects of Atorvastatin in Experimental Colitis

The current therapeutic options for Inflammatory Bowel Diseases (IBD) are limited. Even using common anti-inflammatory, immunosuppressive or biological therapies, many patients become unresponsive to the treatments, immunosuppressed or unable to restrain secondary infections. Statins are cholesterol...

Descripción completa

Detalles Bibliográficos
Autores principales: Basso, Paulo José, Sales-Campos, Helioswilton, Nardini, Viviani, Duarte-Silva, Murillo, Alves, Vanessa Beatriz Freitas, Bonfá, Giuliano, Rodrigues, Cassiano Costa, Ghirotto, Bruno, Chica, Javier Emílio Lazo, Nomizo, Auro, Cardoso, Cristina Ribeiro de Barros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382038/
https://www.ncbi.nlm.nih.gov/pubmed/34434187
http://dx.doi.org/10.3389/fimmu.2021.618365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382038/
https://www.ncbi.nlm.nih.gov/pubmed/34434187
http://dx.doi.org/10.3389/fimmu.2021.618365

Ejemplares similares